212 related articles for article (PubMed ID: 14989227)
1. 131I/123I-metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E; Aktolun C; Baum RP; Bishof-Delaloye A; Buscombe J; Chatal JF; Maffioli L; Moncayo R; Mortelmans L; Reske SN
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):BP132-9. PubMed ID: 14989227
[No Abstract] [Full Text] [Related]
2. 67Ga scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E; Aktolun C; Baum RP; Bishof-Delaloye A; Buscombe J; Chatal JF; Maffioli L; Moncayo R; Mortelmans L; Reske SN
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):BP125-31. PubMed ID: 14989225
[No Abstract] [Full Text] [Related]
3. FDG-PET: procedure guidelines for tumour imaging.
Bombardieri E; Aktolun C; Baum RP; Bishof-Delaloye A; Buscombe J; Chatal JF; Maffioli L; Moncayo R; Mortelmans L; Reske SN
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):BP115-24. PubMed ID: 14989224
[No Abstract] [Full Text] [Related]
4. 111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E; Aktolun C; Baum RP; Bishof-Delaloye A; Buscombe J; Chatal JF; Maffioli L; Moncayo R; Mortelmans L; Reske SN
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):BP140-7. PubMed ID: 14989228
[No Abstract] [Full Text] [Related]
5. Bone scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E; Aktolun C; Baum RP; Bishof-Delaloye A; Buscombe J; Chatal JF; Maffioli L; Moncayo R; Morteímans L; Reske SN
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):BP99-106. PubMed ID: 14989222
[No Abstract] [Full Text] [Related]
6. Breast scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E; Aktolun C; Baum RP; Bishof-Delaloye A; Buscombe J; Chatal JF; Maffioli L; Moncayo R; Mortelmans L; Reske SN
Eur J Nucl Med Mol Imaging; 2003 Dec; 30(12):BP107-14. PubMed ID: 14989223
[No Abstract] [Full Text] [Related]
7. Guidelines for radioiodinated MIBG scintigraphy in children.
Olivier P; Colarinha P; Fettich J; Fischer S; Frökier J; Giammarile F; Gordon I; Hahn K; Kabasakal L; Mann M; Mitjavila M; Piepsz A; Porn U; Sixt R; van Velzen J
Eur J Nucl Med Mol Imaging; 2003 May; 30(5):B45-50. PubMed ID: 12658506
[TBL] [Abstract][Full Text] [Related]
8. EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues.
Vander Borght T; Asenbaum S; Bartenstein P; Halldin C; Kapucu O; Van Laere K; Varrone A; Tatsch K;
Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1374-80. PubMed ID: 16932934
[No Abstract] [Full Text] [Related]
9. PET myocardial glucose metabolism and perfusion imaging: Part 1-Guidelines for data acquisition and patient preparation.
Bacharach SL; Bax JJ; Case J; Delbeke D; Kurdziel KA; Martin WH; Patterson RE
J Nucl Cardiol; 2003; 10(5):543-56. PubMed ID: 14569248
[No Abstract] [Full Text] [Related]
10. FDOPA PET has clinical utility in brain tumour imaging: a proposal for a revision of the recent EANM guidelines.
Talbot JN; Kerrou K; Montravers F; Nataf V; Chevalme Y
Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):1131-2; author reply 1133-4. PubMed ID: 17437107
[No Abstract] [Full Text] [Related]
11. 131I/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging.
Bombardieri E; Giammarile F; Aktolun C; Baum RP; Bischof Delaloye A; Maffioli L; Moncayo R; Mortelmans L; Pepe G; Reske SN; Castellani MR; Chiti A;
Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2436-46. PubMed ID: 20644928
[TBL] [Abstract][Full Text] [Related]
12. European Association of Nuclear Medicine procedure guidelines for brain imaging using [(18)F]FDG.
Bartenstein P; Asenbaum S; Catafau A; Halldin C; Pilowski L; Pupi A; Tatsch K;
Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):BP43-8. PubMed ID: 12436498
[No Abstract] [Full Text] [Related]
13. Good clinical practice: a plea for nuclear medicine.
Otte A; Dierckx RA
Nucl Med Commun; 2005 Jul; 26(7):561. PubMed ID: 15942474
[No Abstract] [Full Text] [Related]
14. [Draft guideline regarding appropriate use of 131I-MIBG radiotherapy for neuroendocrine tumors Drafting Committee for Guideline of Radiotherapy with 131I-MIBG, Committee for Nuclear Oncology and Immunology, The Japanese Society of Nuclear Medicine].
Kinuya S; Yoshinaga K; Higuchi T; Jinguji M; Kawamoto H; Kurihara H
Kaku Igaku; 2015 Feb; 52(1):1-15. PubMed ID: 26502667
[TBL] [Abstract][Full Text] [Related]
15. PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting.
Schelbert HR; Beanlands R; Bengel F; Knuuti J; Dicarli M; Machac J; Patterson R
J Nucl Cardiol; 2003; 10(5):557-71. PubMed ID: 14569249
[No Abstract] [Full Text] [Related]
16. Nuclear medicine imaging of neuroendocrine tumours.
Bombardieri E; Maccauro M; De Deckere E; Savelli G; Chiti A
Ann Oncol; 2001; 12 Suppl 2():S51-61. PubMed ID: 11762353
[TBL] [Abstract][Full Text] [Related]
17. Ten years of experience with MIBG applications and the potential of new radiolabeled peptides: a personal overview and concluding remarks.
Shapiro B
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):150-5. PubMed ID: 9002776
[TBL] [Abstract][Full Text] [Related]
18. The British Thyroid Association guidelines for the management of thyroid cancer in adults.
Watkinson JC;
Nucl Med Commun; 2004 Sep; 25(9):897-900. PubMed ID: 15319594
[No Abstract] [Full Text] [Related]
19. Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET.
Binderup T; Knigge U; Loft A; Mortensen J; Pfeifer A; Federspiel B; Hansen CP; Højgaard L; Kjaer A
J Nucl Med; 2010 May; 51(5):704-12. PubMed ID: 20395333
[TBL] [Abstract][Full Text] [Related]
20. Monitoring the efficacy of iodine-131-MIBG therapy using fluorine-18-FDG-PET.
Menzel C; Graichen S; Berner U; Risse JH; Diehl M; Döbert N; Hamscho N; Grünwald F
Acta Med Austriaca; 2003; 30(2):37-40. PubMed ID: 12752086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
